May 8 |
GAAP EPS of -$3.53 misses by $2.71
|
May 8 |
LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
|
May 1 |
LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024
|
Apr 3 |
LENZ Therapeutics gains as eye therapy succeeds in late-stage trial
|
Apr 3 |
LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials
|
Apr 2 |
LENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia Trials
|
Mar 27 |
Lenz stock rallies 22% amid bullish note by Piper Sandler
|
Mar 21 |
LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress
|
Mar 21 |
11 Stocks that Paid Special Dividends in 2024
|
Mar 11 |
Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
|